Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1137P refers to a specific pseudogene copy of the U6 small nuclear RNA (snRNA) in humans. U6 snRNA is a key structural and catalytic non-coding RNA involved in the spliceosome, the cellular machinery responsible for pre-mRNA splicing[1][3]. However, RNU6-1137P is a *pseudogene* version, meaning it is a non-functional genomic copy generated by retrotransposition, often through LINE-1 (L1)-mediated mechanisms[5]. Pseudogenes like RNU6-1137P are widespread in the genome but do not produce active RNA or protein and do not have known therapeutic target potential or direct roles in disease. They are considered molecular fossils of past genomic activity and may, at most, serve as markers of genomic retrotransposon activity, not as active biomarkers or drug targets[5][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1137, pseudogene (RNU6-1137P).